Long noncoding RNA在Dicer調控之micro-RNA重新編程的角色與sorafenib在肝癌中產生抗藥性的研究探討

Medicine & Life Sciences

1. Drug Resistance 5%
2. Formal Social Control 5%
3. Hepatocellular Carcinoma 23%
4. Liver Neoplasms 80%
5. Long Noncoding RNA 75%
6. MicroRNAs 63%
7. Neoplasms 18%
8. Neoplastic Stem Cells 6%
9. Pharmaceutical Preparations 7%
10. Precision Medicine 6%
11. Preliminary Data 6%
12. Ribonuclease III 8%
13. Sorafenib 100%
14. Survival 6%
15. Taiwan 5%
16. Xenograft Model Antitumor Assays 9%